A Phase 1b Study of Abemaciclib in Combination With Therapies for Patients With Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs Abemaciclib (Primary) ; Anastrozole; Everolimus; Exemestane; Fulvestrant; Letrozole; Loperamide; Pertuzumab; Samotolisib; Tamoxifen; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 04 Nov 2019 Planned End Date changed from 31 Dec 2020 to 28 Oct 2022.
- 04 Nov 2019 Planned primary completion date changed from 31 Mar 2020 to 28 Apr 2021.
- 15 Mar 2019 Planned End Date changed from 16 Dec 2020 to 31 Dec 2020.